Publicaciones en las que colabora con Jorge Manzanares Robles (9)

2023

  1. Regulation of Cortico-Thalamic JNK1/2 and ERK1/2 MAPKs and Apoptosis-Related Signaling Pathways in PDYN Gene-Deficient Mice Following Acute and Chronic Mild Stress

    International journal of molecular sciences, Vol. 24, Núm. 3

2011

  1. Decreased GABAA and GABAB receptor functional activity in cannabinoid CB1 receptor knockout mice

    Journal of Psychopharmacology, Vol. 25, Núm. 1, pp. 105-110

  2. Prodynorphin gene deletion increased anxiety-like behaviours, impaired the anxiolytic effect of bromazepam and altered GABAA receptor subunits gene expression in the amygdala

    Journal of Psychopharmacology, Vol. 25, Núm. 1, pp. 87-95

2005

  1. Neurotransmitter amino acid in cerebrospinal fluid of patients with dementia with Lewy bodies

    Journal of Neural Transmission, Vol. 112, Núm. 4, pp. 557-563

  2. Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain

    Neuropharmacology, Vol. 49, Núm. 5, pp. 618-626

  3. κ- and δ-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice

    European Journal of Neuroscience, Vol. 22, Núm. 8, pp. 2106-2110

2004

  1. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors

    Neuropharmacology, Vol. 46, Núm. 7, pp. 966-973

  2. Role of endocannabinoid system in mental diseases

    Neurotoxicity Research, Vol. 6, Núm. 3, pp. 213-224

2002

  1. Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites are increased in dementia with Lewy bodies

    Neuroscience Letters, Vol. 333, Núm. 2, pp. 151-153